Company / Interest Expense
Tango Therapeutics, Inc. Interest Expense History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$495.0K
FY2022
5-year range
$108.0K / $495.0K
FY2020-FY2022
Trend
+358.3%
vs FY2021
Sector context
#37 of 44
Health Care
What the data says
Interest Expense changed +358% YoY in FY2022, a notable deviation from the 2-year average annual change of +179%.
Based on SEC 10-K filings.
$495,000 in FY2022.
Increased from $108,000 to $495,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 44This company $495.0K Sector average $291.0M
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2022, interest expense increased 358.3% year-over-year.
- Ranks #37 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $495.0K | +358.3% |
| FY2021 | $108.0K | +0.0% |
| FY2020 | $108.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026